(Reuters) – Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc’s continuous glucose monitoring system for three months compared with those who use routine fingerstick testing, researchers said on Saturday.
The study, which was presented at the American Diabetes Association meeting in San Francisco, assessed the medical records of 363 type 2 diabetics in France, Germany and Austria between three and six months.
Dr. Helene Hanaire of the University Hospital Center of Toulouse, France, one of the study authors, said having ready access to their blood glucose readings helped diabetics become more engaged with controlling their glucose levels.
Patients in the study, whose average age was 63, used multiple insulin injections every day over a period of more than eight years.
An analysis of patient records found that patients who used Abbott’s FreeStyle Libre – a device worn on the body that monitors…
Source news reuters.com, click here to read the full news.
